Novartis AG may have violated a Japanese law by promoting its Diovan hypertension medicine as a treatment for cutting stroke risks without sufficient evidence, a breach which could lead to fines and jail terms, according to a government panel.
Americans are egalitarian. This trait has long frustrated plutocrats who, more than a century ago, invented Social Darwinism to teach that the rich prospered because they were smart and productive. Few people believed this, not then and not now.
It has been a tough couple of months for Pennsylvania State University’s new wellness program, Take Care of Your Health. In July, the university introduced the plan as a modification of the health coverage it offers employees. For good reason, those employees aren’t pleased.
Ranbaxy Laboratories Ltd., the Indian drugmaker that agreed to pay $500 million to settle fraud allegations, plunged the most on record after U.S. regulators restricted imports from one of its production facilities.
Ranbaxy Laboratories Ltd. had its rating cut by at least seven brokerages after plans to sell generic versions of two blockbuster pills were frustrated by import restrictions placed on a third Indian production plant.